**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
| 8000-34-8 |Clove oil | | unlisted |
+----------------+--------------------------------------+----------+-----------+
Hazard Symbols: None Listed.
Risk Phrases: None Listed.
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
Not available.
Potential Health Effects
Eye:
May cause eye irritation.
Skin:
May cause skin irritation.
Ingestion:
May cause irritation of the digestive tract.
Inhalation:
May cause respiratory tract irritation.
Chronic:
No information found.
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
Flush eyes with plenty of water for at least 15 minutes,
occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Flush skin with plenty of water for at least 15 minutes while
removing contaminated clothing and shoes. Get medical aid if
irritation develops or persists.
Ingestion:
If victim is conscious and alert, give 2-4 cupfuls of milk or water.
Never give anything by mouth to an unconscious person. Get medical
aid.
Inhalation:
Remove from exposure and move to fresh air immediately. Get medical
aid if cough or other symptoms appear.
Notes to Physician:
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear.
Extinguishing Media:
For small fires, use water spray, dry chemical, carbon dioxide or
chemical foam.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Absorb spill with inert material (e.g. vermiculite, sand or earth),
then place in suitable container.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Wash hands before eating. Use with adequate ventilation. Avoid
contact with skin and eyes. Avoid ingestion and inhalation.
Storage:
Store in a cool, dry, well-ventilated area away from incompatible
substances.
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Use adequate ventilation to keep airborne concentrations low.
Exposure Limits
CAS# 8000-34-8:
Personal Protective Equipment
Eyes:
Wear appropriate protective eyeglasses or chemical
safety goggles as described by OSHA's eye and face
protection regulations in 29 CFR 1910.133 or European
Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin
exposure.
Clothing:
Wear appropriate protective clothing to prevent skin
exposure.
Respirators:
Follow the OSHA respirator regulations found in 29
CFR 1910.134 or European Standard EN 149. Use a
NIOSH/MSHA or European Standard EN 149 approved
respirator if exposure limits are exceeded or if
irritation or other symptoms are experienced.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Liquid
Color: colorless to light yellow
Odor: none reported
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: 482 deg F
Freezing/Melting Point: Not available.
Autoignition Temperature: Not applicable.
Flash Point: Nonflammable.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature: Not available.
Solubility in water: Insoluble in water.
Specific Gravity/Density: 1.0
Molecular Formula: Variable
Molecular Weight: 0
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Stable under normal temperatures and pressures.
Conditions to Avoid:
Strong oxidants.
Incompatibilities with Other Materials:
None reported.
Hazardous Decomposition Products:
Acrid smoke and fumes.
Hazardous Polymerization: Has not been reported.
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 8000-34-8: GF6890000 GF6900000 GF6910000
LD50/LC50:
CAS# 8000-34-8: Draize test, rabbit, skin: 500 mg/24H Severe; Oral,
rat: LD50 = 1370 mg/kg; Oral, rat: LD50 = 2650 mg/kg; Oral, rat:
LD50 = 2020 mg/kg; Skin, rabbit: LD50 = 1200 mg/kg; Skin, rabbit:
LD50 = 5 gm/kg; Skin, rabbit: LD50 = >5 gm/kg.
Carcinogenicity:
Clove oil -
Not listed by ACGIH, IARC, or NTP.
Other:
See actual entry in RTECS for complete information.
**** SECTION 12 - ECOLOGICAL INFORMATION ****
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Products which are considered hazardous for supply are classified as Special
Waste and the disposal of such chemicals is covered by regulations which may
vary according to location. Contact a specialist disposal company or the local
waste regulator for advice. Empty containers must be decontaminated before
returning for recycling.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
Not regulated as a hazardous material.
IMO
Not regulated as a hazardous material.
RID/ADR
Not regulated as a hazardous material.
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: Not available.
Risk Phrases:
Safety Phrases:
WGK (Water Danger/Protection)
CAS# 8000-34-8: No information available.
Canada
CAS# 8000-34-8 is listed on Canada's DSL List.
CAS# 8000-34-8 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 8000-34-8 is listed on the TSCA inventory.
**** SECTION 16 - ADDITIONAL INFORMATION ****
MSDS Creation Date: 12/12/1997 Revision #3 Date: 3/18/2003
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|
| ALL MSDS PAGES IN THIS GROUP
| | NAME | CAS |
|
tert-Butyl 1-piperazinecarboxylate
| 57260-71-6 |
|
Benzyl 1-piperazinecarboxylate
| 31166-44-6 |
|
1-N-BOC-Aminocyclopentanecarboxylic acid
| 35264-09-6 |
|
3-Fluoro-4-(trifluoromethyl)benzoic acid
| 115754-21-7 |
|
Brij?? 78
| 9005-00-9 |
|
7-Methylphthalide, 97%
| 2211-84-9 |
|
4-Aminobenzaldehyde
| 556-18-3 |
|
5-Phenylvaleric acid, 99%
| 2270-20-4 |
|
Aerosil 200
| 112945-52-5 |
|
Brewers yeast
| 68876-77-7 |
|
4-(Trimethylsilyl)-3-butyn-2-one
| 5930-98-3 |
|
Cinnamyl Chloride, 95% Trans
| 21087-29-6 |
|
1,7-Dihydroxynaphthalene, 98%
| 575-38-2 |
|
4-Methoxy-alpha-toluenethiol
| 6258-60-2 |
|
N-Butyl 2-Methylbutyrate, 98+%
| 15706-73-7 |
|
1-Naphthalenemethylamine
| 118-31-0 |
|
3,4-(Methylenedioxy)phenylacetonitrile
| 4439-02-5 |
|
Benzyl isocyanide, 98%
| 10340-91-7 |
|
2,5-Dichlorobenzenethiol, 98%
| 5858-18-4 |
|
Indazole, 96%
| 271-44-3 |
|
1-(2-Bromoethoxy)2-ethoxybenzene
| 3259-03-8 |
|
2,6-Di-tert-butylpyridine, 97%
| 585-48-8 |
|
p-Bromovalerophenone, 98%
| 7295-44-5 |
|
3-(Trifluoromethoxy)aniline, 97% (titr.)
| 1535-73-5 |
|
2-(4-Aminophenyl)-1,1,1,3,3,3-hexafluoro-2 -propanol
| 722-92-9 |
|
4-Hydroxy-6-methyl-3-nitro-2-pyridone
| 4966-90-9 |
|
2-Chloro-3-nitrobenzoic acid
| 3970-35-2 |
|
1,3-Diaminopropane, 99%
| 109-76-2 |
|
Citric acid, anhydrous
| 77-92-9 |
|
Cleaning Solution
| 1333-82-0 |
|
FOLIC ACID
| 59-30-3 |
|
Sodium hydroxide, solid, pellets
| 497-19-8 |
|
Clove Oil
| 8000-34-8 |
|
2,6-Dimethylbenzoic Acid, 99%
| 632-46-2 |
|
Octadecylamine hydrochloride, 99% (titr.)
| 1838-08-0 |
|
Bis(hexylene glycolato)diboron, 97%
| 230299-21-5 |
|
4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)aniline
| 214360-73-3 |
|
5-Bromo-2-Chloropyrimidine
| 32779-36-5 |
|
4-Amino-2-chlorophenol
| 3964-52-1 |
|
5-Chloro-2-mercaptobenzothiazole, 90%
| 5331-91-9 |
|
4-Bromo-2-nitrophenol
| 7693-52-9 |
|
Benzoyleneurea
| 86-96-4 |
|
2-(Aminomethyl)benzimidazole dihydrochloride hydrate
| 5993-91-9 |
|
4-Chlorophenoxyacetyl chloride
| 4122-68-3 |
|
l-Histidine monohydrochloride, 1-hydrate, 98% (titr.)
| 5934-29-2 |
|
3-Amino-5-phenylpyrazole
| 1572-10-7 |
|
N-Benzyl-4-piperidone
| 3612-20-2 |
|
3,5-Dichlorobenzoyl chloride
| 2905-62-6 |
|
Methyl 3-formylbenzoate
| 52178-50-4 |
|
3-Pyrroline
| 109-96-6 |
|
|